PFBT
PRCT icon

Parkside Financial Bank & Trust’s Procept Biorobotics PRCT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50
Closed -$1.25K – 2772
2026
Q1 		$1.25K Buy
50
+5
+11% +$141 ﹤0.01% 2277
2025
Q4 		$1.42K Buy
+45
New +$1.49K ﹤0.01% 2218
2025
Q3 		– Sell
-21
Closed -$1.21K – 2789
2025
Q2 		$1.21K Buy
21
+11
+110% +$622 ﹤0.01% 2184
2025
Q1 		$583 Buy
+10
New +$683 ﹤0.01% 2296

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Parkside Financial Bank & Trust's PRCT Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 50 shares — an estimated $1.25K sold.

Parkside Financial Bank & Trust first reported a position in PRCT in Q1 2025 and held it in 4 quarters. The position peaked at $1.42K in Q4 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Parkside Financial Bank & Trust reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 50 Procept Biorobotics shares in Q2 2026, an estimated $1.25K.
  • Parkside Financial Bank & Trust first reported a position in Procept Biorobotics in Q1 2025 and held it in 4 quarters.
  • Parkside Financial Bank & Trust's Procept Biorobotics position peaked at $1.42K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.